Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Bulletin Du Cancer|January 1, 1992
[Comparison of 2 cisplatin and etoposide dosages in relapsing small cell lung cancer]V Trillet-Lenoir, C Lasset, D Arpin, et al.
Pediatrie|January 1, 1988
[Current results of intensive chemotherapy as salvage with bone marrow graft in highly malignant T lymphomas. Apropos of 10 cases]F Meziane, T Philip, P Biron, et al.
Acta Psychiatrica Belgica|July 1, 1986
[Life events and breast cancer. Initial results of a comparative study dealing with 100 cases and their control]J L Terra, F Amiel-Lebigre, F Boujema, et al.
Cancer Treatment Reviews|June 1, 1989
Interleukin-2 with and without LAK cells in metastatic renal cell carcinoma: the Lyon first-year experience in 20 patientsT Philip, A Mercatello, S Negrier, et al.
British Journal of Cancer|May 1, 1993
Multivariate analysis of prognostic factors in patients with non HIV-related primary cerebral lymphoma. A proposal for a prognostic scoringJ Y Blay, C Lasset, C Carrie, et al.
International Journal of Environmental Research and Public Health|January 5, 2018
Systematic Screening for Occupational Exposures in Lung Cancer Patients: A Prospective French CohortOlivia Pérol, Barbara Charbotel, Lionel Perrier, et al.
Acta Endocrinologica|June 1, 1986
The 24-h cortisol secretory pattern in Cushing's syndromeJ Tourniaire, D Chalendar, B Rebattu, et al.
Presse Medicale (Paris, France : 1983)|October 8, 1983
[Highly malignant non-Hodgkin's lymphoma. Treatment by intensive sequential chemotherapy]B Coiffier, P A Bryon, D Fière, et al.
Bone Marrow Transplantation|October 1, 1991
Intravenous interleukin-2 just after high dose BCNU and autologous bone marrow transplantation. Report of a multicentric French pilot studyS Negrier, J Y Ranchere, I Philip, et al.
BMC Research Notes|June 12, 2010
Factors of interrupting chemotherapy in patients with Advanced Non-Small-Cell Lung CancerRhizlane Belbaraka, Olivier Trédan, Isabelle Ray-Coquard, et al.
Pageof 6